LifeMD, Inc. (LFMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 25M 50M 75M Q3 '21: 24.9M Q4 '21: 27.4M Q1 '22: 29M Q2 '22: 30.5M Q3 '22: 31.4M Q4 '22: 28.1M Q1 '23: 33.1M Q2 '23: 35.9M Q3 '23: 38.6M Q4 '23: 44.9M Q1 '24: 44.1M Q2 '24: 50.7M Q3 '24: 53.3M Q4 '24: 5.5M Q1 '25: 50.9M Q2 '25: 49M Q3 '25: 60.2M Q4 '25: 7.1M Q1 '26: 50.2M Q2 '26: 47.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

-20M 0 20M 40M 60M Q3 '21: 19.9M Q4 '21: 21.8M Q1 '22: 23.8M Q2 '22: 25.8M Q3 '22: 26.7M Q4 '22: 24.1M Q1 '23: 28.9M Q2 '23: 31.4M Q3 '23: 33.8M Q4 '23: 39.5M Q1 '24: 39.5M Q2 '24: 45.6M Q3 '24: 48.3M Q4 '24: -1.3M Q1 '25: 42.8M Q2 '25: 42.2M Q3 '25: 52.8M Q4 '25: 2.8M Q1 '26: 44.2M Q2 '26: 42M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '21: -12.6M Q4 '21: -13.7M Q1 '22: -13.1M Q2 '22: -12.9M Q3 '22: -7.1M Q4 '22: -10.4M Q1 '23: -2.9M Q2 '23: -4.9M Q3 '23: -4.6M Q4 '23: -2.2M Q1 '24: -6.2M Q2 '24: -6.3M Q3 '24: -4M Q4 '24: -6M Q1 '25: -1.2M Q2 '25: -2.3M Q3 '25: -2M Q4 '25: -6.2M Q1 '26: -8.9M Q2 '26: -7.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '21: -14.4M Q4 '21: -18.1M Q1 '22: -13.3M Q2 '22: -13M Q3 '22: -7.3M Q4 '22: -11.9M Q1 '23: -4M Q2 '23: -6.7M Q3 '23: -6.1M Q4 '23: -3.7M Q1 '24: -6.8M Q2 '24: -6.9M Q3 '24: -4.7M Q4 '24: -4.9M Q1 '25: -183.8K Q2 '25: -1.6M Q3 '25: -3.8M Q4 '25: 20M Q1 '26: -8.9M Q2 '26: -7.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 3M 6M 9M Q3 '21: 5.1M Q4 '21: 5.6M Q1 '22: 5.2M Q2 '22: 4.6M Q3 '22: 4.7M Q4 '22: 4.1M Q1 '23: 4.2M Q2 '23: 4.5M Q3 '23: 4.8M Q4 '23: 5.4M Q1 '24: 4.6M Q2 '24: 5M Q3 '24: 5M Q4 '24: 6.8M Q1 '25: 8.1M Q2 '25: 6.8M Q3 '25: 7.4M Q4 '25: 4.2M Q1 '26: 5.9M Q2 '26: 5.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -7.4M Q4 '21: -5.8M Q1 '22: -8.1M Q2 '22: -10.1M Q3 '22: -2.8M Q4 '22: -2M Q1 '23: -2.6M Q2 '23: 4.6M Q3 '23: 1.1M Q4 '23: 5.7M Q1 '24: 5.2M Q2 '24: 4.5M Q3 '24: 6.7M Q4 '24: 1.1M Q1 '25: 3.1M Q2 '25: 8.6M Q3 '25: -147.1K Q4 '25: -3.3M Q1 '26: 444.6K Q2 '26: -6.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -7.5M Q4 '21: -6M Q1 '22: -8.4M Q2 '22: -10.2M Q3 '22: -2.8M Q4 '22: -2M Q1 '23: -2.6M Q2 '23: 4.6M Q3 '23: 1M Q4 '23: 5.6M Q1 '24: 5M Q2 '24: 3.9M Q3 '24: 6.3M Q4 '24: 875.4K Q1 '25: 3M Q2 '25: 7.9M Q3 '25: -968.1K Q4 '25: -3.4M Q1 '26: 339.4K Q2 '26: -7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '20: 10.7M Q2 '20: 12.3M Q3 '20: 14.7M Q1 '21: 24.5M Q2 '21: 26.3M Q3 '21: 26.7M Q1 '22: 30.9M Q2 '22: 30.8M Q3 '22: 30.9M Q1 '23: 31.7M Q2 '23: 32.6M Q3 '23: 34.5M Q1 '24: 39.2M Q2 '24: 41.3M Q3 '24: 42M Q1 '25: 43.1M Q2 '25: 44.4M Q3 '25: 46.2M Q1 '26: 47.3M Q2 '26: 47.8M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.08 -0.05 -0.03 0.00 0.03 0.05 0.08 Q4 '12: -0.03 Q1 '13: -0.03 Q2 '13: -0.02 Q1 '14: 0.00 Q2 '14: 0.00 Q3 '14: 0.00 Q4 '14: -0.01 Q1 '17: -0.06 Q2 '17: -0.03 Q3 '17: -0.04 Q4 '17: -0.04 Q4 '12 Q2 '13 Q2 '14 Q4 '14 Q2 '17 Q4 '17

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.